Jericho Assisted Living
Sunday, November 13, 2016
AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator
(MedPage Today) -- Investigational drug ularitide had no effect on mortality or clinical outcomes
via
AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment